21. 04. 2023 02:11
Liebe Unterstützende,
der Petent oder die Petentin hat innerhalb der letzten 12 Monate nach Ende der Unterschriftensammlung keine Neuigkeiten erstellt und den Status nicht geändert. openPetition geht davon aus, dass die Petition nicht eingereicht oder übergeben wurde.
Wir bedanken uns herzlich für Ihr Engagement und die Unterstützung,
Ihr openPetition-Team
04. 05. 2021 18:18
Sehr geehrte Unterstützende,
die Petition wurde gemäß unserer Nutzungsbedingungen überarbeitet. Die temporäre Sperrung wurde wieder aufgehoben und die Petition kann nun weiter unterzeichnet werden.
Wir bedanken uns für Ihr Engagement!
Ihr openPetition-Team
03. 05. 2021 00:32
Added third-party sources
Новое описание петиции:
In Poland, which is a member of the European Union, our patient Leonard Pietraszak was poisoned during an MRI procedure where Dotarem was used. According to the description of the drug, it is an agent for contrast imaging in magnetic resonance imaging. The drug is in official circulation in the EU countries, which is confirmed by relevant documents.
www.guerbet.com/en-gb/healthcare-professionals/products-solutions/contrast-agents/dotarem
Leonard Pietraszak claims that he was adversely affected by the drug causing toxic poisoning. Leonard Pietraszak says that according to the description, the gadolinium in the drug should be eliminated by kidneys within one week. This did not occur. In addition, he claims that 3.5 months after he underwent the MRI, he visited a treatment facility for tests and was found to have 3 times the amount of gadolinium in his system without excretion in his urine. The patient also claims that he developed systemic fibrosis throughout his body based on his use of Dotarem. This, in turn, resulted in poor vision, his skin no longer being elastic and the first signs of physical exhaustion, which was not the case before he underwent an MRI scan with the drug in question. We consider it necessary to conduct a thorough examination so that competent persons can confirm or refute the fact that the use of the gadolinium-based drug is dangerous for human MRI scans.
Resource
29. 04. 2021 18:16
This is a tip from the openPetition editorial team:
This petition is in conflict with Point 1.4 the terms of use for admissible petitions.
We need sources that proove your statements. There is non proove by Leonard Pietraszak yet.
29. 04. 2021 03:29
Information was added that was accidentally deleted in a previous edit
Новое описание петиции:
In Poland, which is a member of the European Union, our patient Leonard Pietraszak was poisoned during an MRI procedure where Dotarem was used. According to the description of the drug, it is an agent for contrast imaging in magnetic resonance imaging. The drug is in official circulation in the EU countries, which is confirmed by relevant documents.
www.guerbet.com/en-gb/healthcare-professionals/products-solutions/contrast-agents/dotarem
Leonard Pietraszak claims that he was adversely affected by the drug causing toxic poisoning. Leonard Pietraszak says that according to the description, the gadolinium in the drug should be eliminated by kidneys within one week. This did not occur. In addition, he claims that 3.5 months after he underwent the MRI, he visited a treatment facility for tests and was found to have 3 times the amount of gadolinium in his system without excretion in his urine. The patient also claims that he developed systemic fibrosis throughout his body based on his use of Dotarem. This, in turn, resulted in poor vision, his skin no longer being elastic and the first signs of physical exhaustion, which was not the case before he underwent an MRI scan with the drug in question. question. We consider it necessary to conduct a thorough examination so that competent persons can confirm or refute the fact that the use of the gadolinium-based drug is dangerous for human MRI scans.
29. 04. 2021 03:26
Added sources.
More precisely worded sentences.
Новое описание петиции:
In Poland, which is a member of the European Union, oneour ofpatient theLeonard patientsPietraszak receivedwas poisoningpoisoned whileduring undergoingan MRI treatment,procedure where Dotarem was used. According to the description of the drug, it is an agent for contrast imaging in magnetic resonance imaging. The drug is in official circulation in the EU countries, aswhich is confirmed by the relevant documents.
Thewww.guerbet.com/en-gb/healthcare-professionals/products-solutions/contrast-agents/dotarem
Leonard patientPietraszak claims that he was adversely affected by the drug,drug causing toxic poisoning. TheLeonard patientPietraszak claimssays that according to the description, the gadolinium that was in the drug should be eliminated through theby kidneys within one week. This did not happen.occur. In addition, thehe patient allegesclaims that 3.5 months after he underwent the MRI, he visited a treatment facility for tests and was found to have 3 times the amount of gadolinium in his system,system with nowithout excretion throughin thehis urine. The patient also claims that he developed systemic fibrosis throughout his body based on thehis use of Dotarem. This, in turn, hasresulted led to the patient'sin poor vision, his skin ceasingno tolonger bebeing elastic and the first signs of physical exhaustion, which was not the case before he underwent an MRI scan with the drug in question. We consider it necessary to conduct a thorough examination so that competent persons can confirm or refute the fact that the use of the gadolinium-based drug is dangerous for human MRI scans. question.
27. 04. 2021 10:19
This is a tip from the openPetition editorial team:
This petition is in conflict with Point 1.4 the terms of use for admissible petitions.
Please provide sources for your statements.
26. 04. 2021 21:03
Inaccurate wordings have been corrected.
Новое описание петиции:
As it became known from official sources, inIn Poland, which is a member of the European Union, one of the patients received poisoning while undergoing MRI treatment, where Dotarem was used. According to the description of the drug, it is an agent for contrast imaging in magnetic resonance imaging. The drug is in official circulation in the EU countries, as confirmed by the relevant documents.
The patient claims that he was adversely affected by the drug, causing toxic poisoning. The patient claims that according to the description, the gadolinium that was in the drug should be eliminated through the kidneys within one week. This did not happen. In addition, the patient alleges that 3.5 months after he underwent the MRI, he visited a treatment facility for tests and was found to have 3 times the amount of gadolinium in his system, with no excretion through the urine. The patient also claims that he developed systemic fibrosis throughout his body based on the use of Dotarem. This, in turn, has led to the patient's poor vision, his skin ceasing to be elastic and the first signs of physical exhaustion, which was not the case before he underwent an MRI scan with the drug in question. We consider it necessary to conduct a thorough examination so that competent persons can confirm or refute the fact that the use of the gadolinium-based drug is dangerous for human MRI scans.
26. 04. 2021 12:00
This is a tip from the openPetition editorial team:
This petition is in conflict with Point 1.4 the terms of use for admissible petitions.
Please provide sources for your statements.
se odpre v novem zavihku ali oknu
